This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Andreas Weichert: Innovator in Pharmaceutical Chemistry
Introduction
Andreas Weichert is a notable inventor based in Norderstedt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on triaza- and tetraaza-anthracenedione derivatives. His research focuses on developing valuable pharmacologically active compounds that can address various health issues.
Latest Patents
Weichert holds a patent for "Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals." This invention relates to compounds of formula I, which are designed to be effective in treating cardiovascular disorders such as atherosclerosis, thrombosis, coronary artery disease, hypertension, and cardiac insufficiency. The compounds are known to upregulate the expression of the enzyme endothelial nitric oxide (NO) synthase, making them useful in conditions where increased NO levels are desired. The patent also details processes for preparing these compounds and their application as active ingredients in pharmaceuticals.
Career Highlights
Andreas Weichert is currently associated with Sanofi-Aventis Deutschland GmbH, where he continues to advance his research in pharmaceutical development. His work has led to significant advancements in the treatment of cardiovascular diseases, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, Weichert has collaborated with esteemed colleagues such as Hartmut Strobel and Paulus Wohlfart. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Andreas Weichert's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the development of treatments for cardiovascular disorders. His ongoing work at Sanofi-Aventis Deutschland GmbH continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile